LUV Vietnamese Law Search Tiếng Việt

This page shows an unofficial English translation, which may be out of date or inexact. Only the Vietnamese text is authoritative. View this page in Vietnamese

Law 34/2005/QH11

Law on pharmacy

Original

73 articles

Quốc hội

Số: 34/2005/QH11

ngày 14 tháng 06 năm 2005

LUẬT

Dược

Căn cứ vào Hiến pháp nước Cộng hoà xã hội chủ nghĩa Việt Nam năm 1992 đã được sửa đổi, bổ sung theo Nghị quyết số 51/2001/QH10 ngày 25 tháng 12 năm 2001 của Quốc hội khóa X, kỳ họp thứ 10;

  1. Article 1 Governing scope and subjects of application
  2. Article 2 Interpretation of terms
  3. Article 3 State policies on pharmacy
  4. Article 4 National drug reserve
  5. Article 5 State management over drug prices
  6. Article 6 Agencies in charge of state management over pharmacy
  7. Article 7 Pharmacy inspectorate
  8. Article 8 Pharmaceutical societies and associations
  9. Article 9 Prohibited acts
  10. Article 10 Forms of drug trading
  11. Article 11 Conditions and competence for granting certificates of satisfaction of drug trading conditions
  12. Article 12 Certificates of satisfaction of drug-trading conditions
  13. Article 13 Pharmacy practice certificates
  14. Article 14 Fees for grant of certificates of satisfaction of drug trading conditions and pharmacy practice certificates
  15. Article 15 Rights of drug-manufacturing establishments
  16. Article 16 Obligations of drug-manufacturing establishments
  17. Article 17 Drugs prepared at drugstores, medical examination and treatment establishments
  18. Article 18 Rights and obligations of drug-exporting or importing enterprises
  19. Article 19 Entrusted export or import of drugs
  20. Article 20 Scope of import of drugs
  21. Article 21 Drug wholesale establishments
  22. Article 22 Rights of drug wholesale establishments
  23. Article 23 Obligations of drug wholesale establishments
  24. Article 24 Drug-retailing establishments
  25. Article 25 Professional qualifications of owners of drug-retailing establishments or drug retailers
  26. Article 26 Operation scope of drug-retailing establishments
  27. Article 27 Rights of drug retailers and owners of drug-retailing establishments
  28. Article 28 Obligations of drug retailers and owners of drug-retailing establishments
  29. Article 29 Conditions on enterprises providing drug preservation services
  30. Article 30 Rights of enterprises providing drug preservation services
  31. Article 31 Obligations of enterprises providing drug preservation services
  32. Article 32 Conditions on enterprises providing drug assay services
  33. Article 33 Rights of enterprises providing drug assay services
  34. Article 34 Obligations of enterprises providing drug assay services
  35. Article 35 Drug registration
  36. Article 36 Drug circulation
  37. Article 37 Labels of drugs circulated in the market
  38. Article 38 Withdrawal of drugs
  39. Article 39 Planting of medicinal herbs and raising of medicinal animals
  40. Article 40 Quality of materia medica
  41. Article 41 Preservation of materia medica
  42. Article 42 Sale of traditional medicaments and drugs from materia medica at medical examination and treatment establishments
  43. Article 43 Registration and circulation of traditional medicaments and drugs from materia medica
  44. Article 44 Manufacture of traditional medicaments and drugs from materia medica
  45. Article 45 Export, import, wholesale or retail of traditional medicaments and drugs from materia medica
  46. Article 46 Prescriptions
  47. Article 47 Use of drugs
  48. Article 48 Conditions for supply of drugs
  49. Article 49 Assurance of supply of drugs
  50. Article 50 Preparation of drugs in medical examination and treatment establishments
  51. Article 51 Drug information
  52. Article 52 Drug advertisement
  53. Article 53 Scope of drug advertisement
  54. Article 54 Drugs subject to clinical trial
  55. Article 55 Drugs exempt from clinical trial
  56. Article 56 Conditions of clinical trial participants
  57. Article 57 Rights of clinical trial participants
  58. Article 58 Rights of organizations or individuals having drugs subject to clinical trial
  59. Article 59 Obligations of organizations and individuals having drugs subject to clinical trial
  60. Article 60 Rights of organizations undertaking to conduct clinical trials of drugs
  61. Article 61 Obligations of organizations undertaking to conduct clinical trials of drugs
  62. Article 62 Stages and procedures of clinical trials of drugs
  63. Article 63 Drugs on the list of drugs subject to special control
  64. Article 64 Conditions for trading in and use of drugs on the list of drugs subject to special control
  65. Article 65
  66. Article 66 Quality standards of drugs
  67. Article 67 Drug assay
  68. Article 68 Drug assay establishments
  69. Article 69 State-owned drug assay establishments
  70. Article 70 Settlement of complaints about drug quality conclusions
  71. Article 71 Transitional provisions
  72. Article 72 Implementation effect
  73. Article 73 Provisions on implementation detailing and guidance

Basis for the status The publishing source records this status (code HHL) as of Jan 1, 2017.

Spot a mistake on this page?

The text here was extracted by machine from the official publication, and that sometimes goes wrong. Point out the mistake and we will fix it. No account needed.

Links are not accepted in the description.